4//SEC Filing
Silberman David 4
Accession 0001209191-24-001146
CIK 0001176309other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 4:39 PM ET
Size
5.1 KB
Accession
0001209191-24-001146
Insider Transaction Report
Form 4
Silberman David
Chief Financial Officer
Transactions
- Award
Common Stock
2024-01-04+136,500→ 366,500 total
Footnotes (1)
- [F1]Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 11,375 over a three year period starting January 8, 2024. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
Documents
Issuer
ORAMED PHARMACEUTICALS INC.
CIK 0001176309
Entity typeother
Related Parties
1- filerCIK 0001867998
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 4:39 PM ET
- Size
- 5.1 KB